Found 116 matching trials
Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals. PHASE2 There is a mounting evidence of the modulation properties of the major cate...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides PHASE2 The aim of this study is to examine the therapeutic effect of green tea ext...
Show More Location
Taipei City Hospital
Learn More & Join Trial
Oral or Topical Catechins for Radiation Dermatitis PHASE3 Introduction Radiation-induced dermatitis (RID), which includes both acute ...
Show More Status
Enrolling By Invitation
Learn More & Join Trial
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors PHASE1 The primary objective of the study is to determine the maximum tolerated do...
Show More Learn More & Join Trial
Sentinel Node Resection With or Without LECS After Noncurative ESD for EGC NA For patients with non-curative resection after endoscopic submucosal dissec...
Show More Location
Karolinska University Hospital Huddinge
Learn More & Join Trial
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids PHASE2 Uterine Leiomyomata, also known as uterine fibroids, are non-cancer tumors ...
Show More Location
Meharry Medical College
Learn More & Join Trial
Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids NA Randomized (1:1) double-blind, single-center controlled trial to evaluate t...
Show More Location
AOUI Verona - University of Verona - Department of Obstetrics and Gynecology
Learn More & Join Trial
Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate) PHASE2 Dystrophic epidermolysis bullosa hereditaria are genodermatosis responsible...
Show More Location
Dermatology Department, Bordeaux University Hospital
Learn More & Join Trial
PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers N/A PENSA+ is a 5-year follow-up study of participants who previously completed...
Show More Location
Fundació Pasqual Maragall
Learn More & Join Trial
Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients PHASE2 Traumatic brain injury is the leading cause of death and disability in youn...
Show More Learn More & Join Trial